✦ LIBER ✦

Personalized molecular targeted therapy in advanced, recurrent hepatocellular carcinoma after liver transplantation: A proof of principle

✍ Scribed by Sherrie Bhoori; Sara Toffanin; Carlo Sposito; Alessandro Germini; Alessandro Pellegrinelli; Andrea Lampis; Vincenzo Mazzaferro

Book ID: 116652112
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 837 KB
Volume: 52
Category: Article
ISSN: 0168-8278
DOI: 10.1016/j.jhep.2010.01.025

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sorafenib in Advanced Hepatocellular Car

Sorafenib in Advanced Hepatocellular Carcinoma: A Further Step Toward Personalized Therapy of Liver Cancer

✍ Massimo Colombo 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 162 KB

Usefulness of chemotherapy as prophylaxi

Usefulness of chemotherapy as prophylaxis of tumor recurrence after liver transplantation in advanced hepatocellular carcinomas

✍ N.J De la Revilla; J.M Moreno; E Rubio; T.A de Herreros; E Navarrete; M.J Lopez; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Locoregional Therapy-Induced Tumor Necro

Locoregional Therapy-Induced Tumor Necrosis as a Predictor of Recurrence after Liver Transplant in Patients with Hepatocellular Carcinoma

✍ Meng-Hsing Ho; Chih-Yung Yu; Kuo-Piao Chung; Teng-Wei Chen; Heng-Cheng Chu; Chih 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 555 KB

A comparative study of pathological stag

A comparative study of pathological staging systems in predicting recurrent hepatocellular carcinoma after liver transplantation

✍ Okuno, Tomoko ;Tsuruyama, Tatsuaki ;Haga, Hironori ;Ueda, Mikiko ;Takada, Yasuts 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 207 KB

Radiofrequency Ablation of Recurrent Hep

Radiofrequency Ablation of Recurrent Hepatocellular Carcinoma in a Patient after Liver Transplantation: Two-year Follow-up

✍ Ho, Chanda K.; Chapman, William C.; Brown, Daniel B. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 317 KB

Efficacy and safety of sorafenib in comb

Efficacy and safety of sorafenib in combination with mammalian target of rapamycin inhibitors for recurrent hepatocellular carcinoma after liver transplantation

✍ Carlos Gomez-Martin; Javier Bustamante; Javier F. Castroagudin; Magdalena Salced 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 185 KB 👁 1 views

There is currently no consensus on the most suitable treatment for the recurrence of hepatocellular carcinoma (HCC) after liver transplantation. This open, multicenter, retrospective, uncontrolled cohort study was designed to evaluate the safety and preliminary efficacy of the combined use of a mamm